Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CADL — Candel Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,347,771
+$1,794,204 QoQ
Shares Held
227,939
+101.8% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 138 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Derivatives in CADL

reported options exposure · as of Jun 30, 2026
CallValue
$1,175,230
CallShares
114,100
PutValue
$202,910
PutShares
19,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. CADL ranks #79 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,347,771 227,939
2026-06-30 $1,175,230 114,100
2026-06-30 $202,910 19,700
2026-03-31 $813,890 166,100
2026-03-31 $553,567 112,973
2026-03-31 $691,880 141,200
2025-12-31 $776,355 137,408
2025-12-31 $412,450 73,000
2025-12-31 $172,325 30,500
2025-09-30 $477,870 93,700
2025-09-30 $401,880 78,800
2025-09-30 $1,141,487 223,821
2025-06-30 $834,394 164,900
2025-06-30 $596,574 117,900
2025-06-30 $1,787,687 353,298
2025-03-31 $1,430,015 253,100
2025-03-31 $1,184,805 209,700
2025-03-31 $1,362,638 241,175
2024-12-31 $5,741,820 661,500
2024-12-31 $3,213,336 370,200
2024-12-31 $2,555,765 294,443
2024-09-30 $938,703 135,455
2024-09-30 $163,548 23,600
2024-09-30 $446,292 64,400
2024-06-30 $258,540 41,700
2024-06-30 $140,740 22,700